Copper peptides – typically GHK-Cu (glycyl-L-histidyl-L-lysine copper) – are among the most researched signal peptides in cosmetic science. GHK-Cu is a naturally occurring tripeptide found in human plasma, urine, and saliva that binds copper ions and has been shown to influence a range of wound healing and remodelling processes in the skin.
The mechanism of action is broad. GHK-Cu stimulates collagen, elastin, and glycosaminoglycan synthesis. It increases the activity of antioxidant enzymes including superoxide dismutase and reduces the expression of TNF-alpha, an inflammatory cytokine. It also activates metalloproteinases that clear damaged collagen – a remodelling function, not pure breakdown – which is why copper peptides can genuinely improve skin quality rather than just masking it.
Research by Loren Pickart, who isolated GHK-Cu in the 1970s, showed that the peptide directed fibroblasts toward repair and regeneration. More recent in vitro and in vivo studies have confirmed improvements in skin laxity, fine lines, and barrier function with consistent use.
Copper peptides are often positioned as a retinol alternative, but the evidence base is different – retinol has a larger and longer clinical history. A more accurate framing is that they’re complementary: retinol primarily drives cell turnover; copper peptides primarily support structural protein synthesis and skin remodelling. They can be used in the same routine, but some formulators recommend spacing them to allow optimal skin receptor activity.
Concentrations in cosmetic products typically run 0.5-3%. The blue-green colour characteristic of copper-containing products is normal – it’s the copper ion. Products that are colourless have likely chelated or degraded the copper, reducing efficacy.